AI
Tuesday, August 22, 2023 2:11:04 PM
Beartrap, thanks for sharing your thoughts, I have previously stated my belief that the additional pages relate to being licensed for rGBM as well as nGBM. Other possibilities for licensing could align with the PIM designation below:-
The PIM designation for DCVax-L covers all malignant gliomas, which would include both Glioblastoma multiforme (the most severe grade) as well as less malignant grades. and would include both newly diagnosed and recurrent gliomas
The PIM designation for DCVax-L covers all malignant gliomas, which would include both Glioblastoma multiforme (the most severe grade) as well as less malignant grades. and would include both newly diagnosed and recurrent gliomas
Bullish
